Ultrasound contrast test for pancreatic cyst diagnosis
Part of Cancer, Digestive system clinical trials.
This study tests a new ultrasound technique to better see the material inside pancreatic cysts, which may help doctors decide if the cyst is benign or needs treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for an endoscopic ultrasound to check a pancreatic cyst.
- The cyst contains material of unknown type that is at least 3 millimeters wide.
- You are covered by French social security.
- You can speak French.
- You agree to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new imaging technique called SMI (Superb Vascular Imaging) to better understand pancreatic cysts that are not yet diagnosed. It may help doctors decide if a cyst is harmless or needs treatment, avoiding unnecessary procedures.
This study tests two new ultrasound techniques to better tell apart pancreatic cancer from other solid growths in the pancreas. If you have a solid pancreas mass, the results could help doctors choose the most appropriate treatment without unnecessary surgery.
This study tests a new lab test called PanCystPro that looks at fluid taken from a pancreatic cyst during an endoscopic ultrasound. It aims to help doctors better manage your condition.
This study looks at using MRI scans to find pancreatic cancer early in people who have certain types of pancreatic cysts that may raise their risk. If you have these cysts, joining could help catch any cancer sooner, when it might be easier to treat.
This trial tests a special camera (confocal laser endomicroscopy) used during an ultrasound-guided needle biopsy to help tell what type of pancreatic cyst is present. It may help doctors decide faster whether surgery is needed.
This study compares different ways to monitor pancreatic cysts and also measures blood or other test markers to see which approach is more helpful. It may help patients by finding the safest, most effective way to track certain cysts that could otherwise be hard to manage.
Hear when a new Papillary and Mucinous Intraductal Tumours of the Pancreas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.